The Covid-19 outbreak has resulted in an unprecedented scenario, with the government issuing notifications on lockdowns across cities to ensure public safety. Complying with the government directive, Dabur has temporarily suspended production at its manufacturing units till March 31, except for essential products such as ayurvedic medicines, Chyawanprash, hand sanitisers, hand wash, etc., in the larger public interest.
A press note issued by Dabur stated, “The situation is still dynamic and uncertain and it is difficult to evaluate or quantify the impact at this point of time. A lot will depend on the stabilisation of the overall scenario arising from the Covid-19 pandemic.”
The note stated, “As an ayurvedic healthcare company, we have responded to the growing consumer needs and increased production and supply of products like Chyawanprash, Giloy, Honitus, etc., in addition to fast-tracking the introduction of hand sanitisers. We have also enhanced supplies to e-commerce.”
The company has also undertaken various measures for the safety of its staff, including work from home, meetings through video conferencing, improved sanitisation of premises, etc.
The noted ended with the statement, “We believe this disruption is extraordinary and temporary in nature. We expect the business to revive once the situation improves. We are planning to stay the course in terms of our strategy and operations and will continue to invest behind our brands and business. We have a strong product portfolio and wide distribution network, which we plan to leverage and pave the way for normalisation in the next few months.”